Friday, 25 September 2020

Johnson & Johnson COVID Vaccine Produces Strong Immune Response In Trial

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results...

from NDTV News - Special https://ift.tt/3jhU577
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Rs 5 Lakh Lump Sum vs Rs 5,000 Monthly SIP: Which Creates More Wealth?

Lump sum and Systematic Investment Plan (SIP) are two popular ways of investing in mutual funds. While lump sum involves investing a large a...